$SYN News Article - Synthetic Biologics Announces
Post# of 219
(Total Views: 250)
Posted On: 09/27/2022 12:20:51 PM
$SYN News Article - Synthetic Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients https://marketwirenews.com/news-releases/synt...99262.html
(0)
(0)Theriva Biologics, Inc. (TOVX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼